Pancreatic Cancer Research

Clinical trialPhase 3Terminated

Carbon Ion RT for Locally Advanced Pancreatic Cancer

A Prospective, Randomized, Phase 3 Trial of Carbon Ion Radiation Therapy Versus Standard Care for Locally Advanced Pancreatic Cancer

Outcome
Stopped earlyStudy administratively closed out by the Einstein IRB. NO US enrolling sites. (Enrollment)
Phase
Phase 3
Status
Terminated
Study type
Interventional
Start
1 November 2020
Ended
24 August 2022
Enrollment
5 participants
Sites
1
Primary outcomes
Overall survival duration
Sponsor type
Academic / other
Results posted
No
Last update
5 January 2024

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

This is an open-label randomized trial. Subjects will be randomized in a 2:1 ratio to receive carbon ion radiotherapy versus standard care for locally advanced pancreatic cancer. Subjects who receive carbon ion radiotherapy may receive additional chemotherapy afterwards, at the discretion of the treating physicians. Subjects on the control arm are also expected to receive chemotherapy, using a regimen selected by the treating physicians. Subjects on the control arm will not receive upfront radiotherapy but may receive radiotherapy (not carbon ion radiotherapy) if disease progression occurs.